Summary

Aneuploidy, the gain or loss of whole chromosomes, is a critical source of reproductive failure, congenital disorders and tumourigenesis. In germ cell systems, errors in meiotic chromosome segregation arise from defects in crossover formation, kinetochore–spindle attachments and checkpoint signalling. Physical agents such as ionising radiation and heat, chemical aneugens that target microtubule dynamics, and genotypic factors including point mutations or chromosomal rearrangements all contribute to nondisjunction. Germ cells of model organisms—from yeast and Drosophila to mice and human spermatozoa—have revealed conserved mechanisms by which spindle disruption, reduced chiasma frequency and cohesion fatigue lead to the formation of univalents and lagging chromosomes. Advances in cytogenetic assays, fluorescence in situ hybridisation and high-throughput sperm aneuploidy screening have refined our ability to detect low-frequency events. Understanding how environmental agents and therapeutic drugs induce aneuploidy in germ cells informs risk assessment for fertility, guides safer drug design and improves our knowledge of transgenerational genetic stability.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Research from all publishers

Recent work in a mammalian model has demonstrated that the chemotherapeutic agent epirubicin not only breaks DNA but also acts as an aneugen in male germ cells. By combining BrdU incorporation to monitor meiotic progression with centromere-specific probes, researchers showed a 48-hour delay in meiosis and significant increases in disomic sperm for chromosomes X, Y and autosome 8. Notably, a bias towards XX and YY sperm implies missegregation at the second meiotic division, highlighting drug-induced spindle malfunction as a source of aneuploid gametes.

Foundational genetic analyses in Drosophila melanogaster females have elucidated how reduced crossover frequency and distributive pairing influence nondisjunction. Early studies demonstrated that inversion heterozygosity, radiation and heat shock generate univalent chromosomes that fail to align correctly on the metaphase plate. These univalents, when of compatible size, may undergo nonhomologous pairing, leading to mis-oriented segregation and resultant aneuploid oocytes.

Methodological advances in direct human gamete assessment have been exemplified by fluorescent staining of sex chromosomes in sperm. A key study employed quinacrine dihydrochloride staining to quantify Y chromosome disomy in ejaculated spermatozoa. This approach bypasses invasive sampling, enabling rapid evaluation of occupational or therapeutic exposures as a predictor for broader autosomal missegregation. Such non-invasive screening is now considered a valuable barometer for assessing reproductive risk in exposed populations.

Aneuploidy Induction in Germ Cell Systems publication trend

The graph below shows the total number of articles in aneuploidy induction in germ cell systems across all publications each year (not limited to Nature Index journals).

Technical terms

Aneuploidy: The state of having a chromosome number that is not an exact multiple of the haploid complement.

Germ cell: A reproductive cell (sperm or oocyte) that undergoes meiosis to produce gametes.

Nondisjunction: Failure of homologous chromosomes or sister chromatids to separate properly during cell division.

Aneugen: An agent that induces aneuploidy by disrupting the mitotic or meiotic spindle apparatus without necessarily causing DNA breaks.

Micronucleus: A small extranuclear body containing one or more whole chromosomes or chromosomal fragments, indicative of genomic instability.

References

  1. Aneugenic Effects of Epirubicin in Somatic and Germinal Cells of Male Mice. PLOS ONE (2014).
  2. Origin of meiotic nondisjunction in Drosophila females.. Environmental Health Perspectives (1979).
  3. Mechanisms of nondisjunction induction in drosophila oocytes.. Environmental Health Perspectives (1979).
  4. Detection of aneuploidy in human sperm.. Environmental Health Perspectives (1979).

About these summaries

This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.

Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.